A phase I study of a combination of yttrium-90-labeled anti-carcinoembryonic antigen (CEA) antibody and gemcitabine in patients with CEA-producing advanced malignancies
about
Combination of antibody targeting and PTD-mediated intracellular toxin delivery for colorectal cancer therapyT cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis.The immune response to tumors as a tool toward immunotherapy.Exploring Glycan Markers for Immunotyping and Precision-targeting of Breast Circulating Tumor Cells.Recombinant bispecific monoclonal antibodies prepared by the dock-and-lock strategy for pretargeted radioimmunotherapy.The new golden era for radioimmunotherapy: not just for lymphomas anymore.General overview of radioimmunotherapy of solid tumors.A novel homogeneous time-resolved fluoroimmunoassay for carcinoembryonic antigen based on water-soluble quantum dots.Combination radioimmunotherapy and chemoimmunotherapy involving different or the same targets improves therapy of human pancreatic carcinoma xenograft models.Carcinoembryonic antigen interacts with TGF-{beta} receptor and inhibits TGF-{beta} signaling in colorectal cancers.Novel anticarcinoembryonic antigen antibody-drug conjugate has antitumor activity in the existence of soluble antigenGlycan Markers as Potential Immunological Targets in Circulating Tumor Cells.
P2860
Q34616158-716661E7-2180-4F0B-9987-4F8C34000E9AQ34621730-F4325D4C-47FF-4971-96D8-3C7F2339DFF8Q34634545-C1134B26-D876-46AD-A409-1ED515227B06Q36510283-E2E8ACA4-4E67-47D0-BB71-AA04B172CAACQ37720857-17B46965-9B8F-409D-963D-8A4D965B49B8Q38072815-F1A2E17F-7D3B-4D91-A1D0-CFBBACAE6712Q38103579-1D9A7EB2-8583-4E6E-8880-5834C8AB36F9Q39455235-BD018C89-99B6-418F-9907-C288429C78F4Q39564060-0B476479-79B8-4C2E-A649-D659846D9408Q39648681-EC0CFF22-B5B2-4525-8AC4-588D78AF9175Q42060421-509F3A7D-E1E3-42C5-931B-81B5D67AD99AQ48787612-673FEFC7-633E-4637-996D-47EB72A471BE
P2860
A phase I study of a combination of yttrium-90-labeled anti-carcinoembryonic antigen (CEA) antibody and gemcitabine in patients with CEA-producing advanced malignancies
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
A phase I study of a combinati ...... roducing advanced malignancies
@ast
A phase I study of a combinati ...... roducing advanced malignancies
@en
type
label
A phase I study of a combinati ...... roducing advanced malignancies
@ast
A phase I study of a combinati ...... roducing advanced malignancies
@en
prefLabel
A phase I study of a combinati ...... roducing advanced malignancies
@ast
A phase I study of a combinati ...... roducing advanced malignancies
@en
P2093
P2860
P1476
A phase I study of a combinati ...... roducing advanced malignancies
@en
P2093
Andrew Raubitschek
Jeffrey Y C Wong
Jiping Zhan
Lawrence Williams
Lucille Leong
Marianna Koczywas
Stephen Shibata
P2860
P304
P356
10.1158/1078-0432.CCR-08-2213
P407
P577
2009-04-07T00:00:00Z